FI874414A0 - CONTROLLED PHARMACEUTICAL COMPOSITION. - Google Patents

CONTROLLED PHARMACEUTICAL COMPOSITION.

Info

Publication number
FI874414A0
FI874414A0 FI874414A FI874414A FI874414A0 FI 874414 A0 FI874414 A0 FI 874414A0 FI 874414 A FI874414 A FI 874414A FI 874414 A FI874414 A FI 874414A FI 874414 A0 FI874414 A0 FI 874414A0
Authority
FI
Finland
Prior art keywords
pharmaceutical composition
controlled pharmaceutical
controlled
composition
pharmaceutical
Prior art date
Application number
FI874414A
Other languages
Finnish (fi)
Other versions
FI874414A (en
Inventor
Henry C Gan
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI874414A0 publication Critical patent/FI874414A0/en
Publication of FI874414A publication Critical patent/FI874414A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2004Excipients; Inactive ingredients
    • A61K9/2022Organic macromolecular compounds
    • A61K9/205Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
FI874414A 1986-10-09 1987-10-07 CONTROLLED PHARMACEUTICAL COMPOSITION. FI874414A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB868624213A GB8624213D0 (en) 1986-10-09 1986-10-09 Sustained release pharmaceutical compositions

Publications (2)

Publication Number Publication Date
FI874414A0 true FI874414A0 (en) 1987-10-07
FI874414A FI874414A (en) 1988-04-10

Family

ID=10605478

Family Applications (1)

Application Number Title Priority Date Filing Date
FI874414A FI874414A (en) 1986-10-09 1987-10-07 CONTROLLED PHARMACEUTICAL COMPOSITION.

Country Status (24)

Country Link
JP (1) JPS63101334A (en)
KR (1) KR880004801A (en)
AU (1) AU7942087A (en)
BE (1) BE1000732A5 (en)
CA (1) CA1332809C (en)
CH (1) CH675831A5 (en)
DE (1) DE3733540A1 (en)
DK (1) DK527487A (en)
ES (1) ES2014518A6 (en)
FI (1) FI874414A (en)
FR (1) FR2604902B1 (en)
GB (2) GB8624213D0 (en)
GR (1) GR871550B (en)
HU (1) HU201875B (en)
IL (1) IL84104A0 (en)
IT (1) IT1221493B (en)
LU (1) LU87009A1 (en)
NL (1) NL8702294A (en)
NO (1) NO874200L (en)
NZ (1) NZ222083A (en)
PH (1) PH24227A (en)
PT (1) PT85880B (en)
SE (1) SE8703889L (en)
ZA (1) ZA877617B (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948437A (en) * 1996-05-23 1999-09-07 Zeneca Limited Pharmaceutical compositions using thiazepine
US5895663A (en) * 1997-07-31 1999-04-20 L. Perrigo Company Pseudoephedrine hydrochloride extended-release tablets
CA2371940C (en) * 1999-03-31 2008-07-15 Janssen Pharmaceutica N.V. Pregelatinized starch in a controlled release formulation
US6242003B1 (en) 2000-04-13 2001-06-05 Novartis Ag Organic compounds
US20060127474A1 (en) 2001-04-11 2006-06-15 Oskar Kalb Pharmaceutical compositions comprising fluvastatin
SE0102888D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102887D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
SE0102886D0 (en) * 2001-08-29 2001-08-29 Astrazeneca Ab New formulation
TWI338583B (en) 2004-05-20 2011-03-11 Otsuka Pharma Co Ltd Solid pharmaceutical formulation
WO2006028362A1 (en) * 2004-09-09 2006-03-16 Psicofarma, S.A. De C.V. Pharmaceutical composition for the sustained release of hydralazine and use thereof as a support for cancer treatment

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE795766A (en) * 1972-02-22 1973-08-22 Lilly Co Eli PROPOXYPHENE DELAY NAPSYLATE PARTICLES AND PROCESS FOR MANUFACTURING SUCH PARTICLES
US4389393A (en) * 1982-03-26 1983-06-21 Forest Laboratories, Inc. Sustained release therapeutic compositions based on high molecular weight hydroxypropylmethylcellulose
US4520009A (en) * 1983-11-28 1985-05-28 Verex Laboratories, Inc. Sustained released aspirin formulation
DE3346571A1 (en) * 1983-12-23 1985-07-04 Bayer Ag, 5090 Leverkusen ORAL RETARDED ACETYLSALICYL ACID FORMULATIONS
JPS61501511A (en) * 1984-03-21 1986-07-24 アメリカン・ホ−ム・プロダクツ・コ−ポレイション sustained release pharmaceutical capsules

Also Published As

Publication number Publication date
GB2195893B (en) 1991-05-08
FR2604902B1 (en) 1991-04-26
ES2014518A6 (en) 1990-07-16
HU201875B (en) 1991-01-28
GB2195893A (en) 1988-04-20
LU87009A1 (en) 1988-05-03
NO874200L (en) 1988-04-11
GB8624213D0 (en) 1986-11-12
PT85880B (en) 1990-07-31
AU7942087A (en) 1988-04-14
IT8748469A0 (en) 1987-10-08
SE8703889L (en) 1988-04-10
IL84104A0 (en) 1988-03-31
NL8702294A (en) 1988-05-02
BE1000732A5 (en) 1989-03-21
SE8703889D0 (en) 1987-10-08
PT85880A (en) 1987-11-01
CH675831A5 (en) 1990-11-15
KR880004801A (en) 1988-06-27
DK527487D0 (en) 1987-10-08
IT1221493B (en) 1990-07-06
ZA877617B (en) 1989-05-30
GR871550B (en) 1988-02-15
GB8723515D0 (en) 1987-11-11
DE3733540A1 (en) 1988-04-14
PH24227A (en) 1990-05-04
FI874414A (en) 1988-04-10
CA1332809C (en) 1994-11-01
NO874200D0 (en) 1987-10-07
DK527487A (en) 1988-04-10
NZ222083A (en) 1991-05-28
HUT52958A (en) 1990-09-28
JPS63101334A (en) 1988-05-06
FR2604902A1 (en) 1988-04-15

Similar Documents

Publication Publication Date Title
DE3761146D1 (en) DETERGENS COMPOSITION.
DE3773631D1 (en) POLYAETHYLENE COMPOSITION.
FI901102A0 (en) PHARMACEUTICAL COMPOSITION.
FI922364A (en) PHARMACEUTICAL COMPOSITION.
DE3884461D1 (en) ANTIBIOTIC-POLYMER COMPOSITION.
DE3870011D1 (en) HARDBUTTER COMPOSITION.
FI883238A (en) MICROBICID COMPOSITION.
IT8721411A0 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N ACETYLSYSTEINE.
DE3779948D1 (en) OXYGENAL COMPOSITION.
IT8721410A0 (en) WATER-SOLUBLE PHARMACEUTICAL COMPOSITION CONTAINING N ACETYLCISTEINE.
FI893643A0 (en) PHARMACEUTICAL COMPOSITION.
FI872733A (en) PHARMACEUTICAL COMPOSITION.
FI872313A (en) PHARMACEUTICAL COMPOSITION.
DE3779951D1 (en) STICKYING COMPOSITION.
FI883673A0 (en) PHARMACEUTICAL COMPOSITION.
FI880158A0 (en) DIURETICAL COMPOSITION.
IT1213453B (en) PHARMACEUTICAL COMPOSITION.
DE3869471D1 (en) Fever-increasing composition.
FI874483A (en) HERBICID COMPOSITION.
DE3874071D1 (en) CONTENT-PREVENTING COMPOSITION.
FI874414A0 (en) CONTROLLED PHARMACEUTICAL COMPOSITION.
DE3773805D1 (en) COMPOSITION.
DE3773298D1 (en) ANESTHESIC COMPOSITION.
DE3875535D1 (en) BUTEN-1-COPOLYMER COMPOSITION.
FI875616A0 (en) PHARMACEUTICAL BLANDNINGAR.

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SANDOZ AG